Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 7NSCLC 2Meningeal Carcinomatosis 2Bronchial Neoplasms 2Brain Neoplasms 2Non-Small Cell Lung Cancer With EGFR T790M Mutation 1Neurocognitive 1Advanced Non-small Cell Lung Cancer 1

Interventions

osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neurocognitive × osimertinib × Clear all
NCT04829019 2021-04-02

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Sun Yat-sen University

Phase 2 Unknown
88 enrolled

Neurocognitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡